News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Equipo de Agomab
Asabys portfolio company Agomab Therapeutics completes Nasdaq IPO
Financing
Partners - Asabys Partners
Equipo de Pharmacelera
Pharmacelera raises €6 million to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform
Financing
The investment round was led by investment fund manager Heran Partners, with participation from…
Partners - Parc Científic de Barcelona
Ivan Borrego (Founder & CEO de IB Corporate Growth) y Eloi Barceló (Business Development Director de Klinea)
Klinea strengthens its growth in the cosmetics industry through a strategic alliance with Ivan Borrego
Healthcare
The incorporation of advanced biotechnological assets—such as proteins, peptides, fermented…
Partners - Klinea Biotech & Pharma Engineering
Entrega de los Premios Natac en la sede del CSIC, en Madrid
Natac presents its National Awards for Research in Natural Products
Corporate
These awards recognize scientific excellence in the field of natural products and their…
Partners - Natac Group
EDIFICIO ORYZON
ORYZON announces appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Healthcare · Talento
Based in New Jersey (USA), to lead ORYZON’s CNS clinical development.
Partners - Oryzon Genomics
Miembros del equipo de Gyala Therapeutics
Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute leukemias with limited treatment options
Healthcare · Advanced therapies
The study has been initiated at Hospital La Fe in Valencia and Hospital Clínic Barcelona, two…
Partners - Invivo Partners, S.G.E.I.C, S.A
Recreación de un cáncer de pulmón de células pequeñas
ORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadademstat in extensive stage small cell lung cancer
Healthcare · Innovative drugs
The study, led by Yale University, explore the combination with atezolizumab and radiation therapy.
Partners - Oryzon Genomics
Profesor Ignacio Martín-Loeches
Viva In Vitro appoints Professor Ignacio Martín-Loeches to its Medical Advisory Board, strengthening its international clinical leadership in sepsis
Healthcare · Talento
Dr Ignacio Martín-Loeches joins Viva In Vitro Diagnostics as an advisor to its Medical Advisory…
Partners - VIVA IN VITRO
Gráfico que muestra los indicadores de Génesis Biomed
GENESIS Biomed closes 2025 with record growth and greater impact on the biomedical ecosystem
Corporate
GENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects…
Partners - GENESIS Biomed